DJ Catalyst Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Catalyst Pharmaceuticals Inc. $(CPRX)$ rose 3.35% to $20.34 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 1.39% to 21,681.90 and the Dow Jones Industrial Average rising 1.10% to 44,458.61.
Catalyst Pharmaceuticals Inc. closed 23.48% below its 52-week high of $26.58, which the company reached on June 9th.
The stock outperformed some of its competitors Tuesday, as Johnson & Johnson $(JNJ)$ fell 0.60% to $172.78, Pfizer Inc. $(PFE)$ rose 0.28% to $24.65, and Abbott Laboratories $(ABT)$ fell 0.26% to $131.02.
Trading volume (1.1 M) remained 297,816 below its 50-day average volume of 1.4 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 12, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
August 12, 2025 17:24 ET (21:24 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。